FSM Wealth Advisors LLC Buys Shares of 1,025 CME Group Inc. (NASDAQ:CME)

FSM Wealth Advisors LLC acquired a new position in CME Group Inc. (NASDAQ:CME) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 1,025 shares of the financial services provider’s stock, valued at approximately $226,000.

Other institutional investors have also made changes to their positions in the company. Y.D. More Investments Ltd acquired a new stake in CME Group during the second quarter worth about $36,000. Thurston Springer Miller Herd & Titak Inc. boosted its holdings in CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after purchasing an additional 74 shares in the last quarter. McClarren Financial Advisors Inc. boosted its holdings in CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares in the last quarter. Asset Dedication LLC boosted its holdings in CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares in the last quarter. Finally, New Covenant Trust Company N.A. acquired a new stake in CME Group during the first quarter valued at approximately $82,000. 87.75% of the stock is currently owned by institutional investors.

Insider Buying and Selling at CME Group

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 15,621 shares of company stock worth $3,441,063. Insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

CME has been the topic of a number of recent research reports. Barclays lifted their price objective on CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a report on Thursday, October 24th. Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a report on Tuesday, October 8th. The Goldman Sachs Group lifted their price objective on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a report on Thursday, October 3rd. JPMorgan Chase & Co. lifted their target price on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Finally, Piper Sandler lifted their target price on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research note on Monday, October 28th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $222.73.

CME Group Stock Performance

CME stock opened at $225.19 on Wednesday. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. The company has a 50 day moving average price of $221.24 and a 200 day moving average price of $209.67. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.36. The stock has a market capitalization of $81.09 billion, a PE ratio of 23.68, a price-to-earnings-growth ratio of 5.62 and a beta of 0.55.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.25 EPS. Analysts forecast that CME Group Inc. will post 10.23 EPS for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.04%. The ex-dividend date was Monday, September 9th. CME Group’s payout ratio is 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.